{"Symbol": "ATYR", "AssetType": "Common Stock", "Name": "aTyr Pharma, Inc.", "Description": "aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company is headquartered in San Diego, California.", "CIK": "1339970", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "10240 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121", "OfficialSite": "https://atyrpharma.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "87590000", "EBITDA": "-77978000", "PERatio": "None", "PEGRatio": "None", "BookValue": "0.819", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.83", "RevenuePerShareTTM": "0.002", "ProfitMargin": "0", "OperatingMarginTTM": "-140.76", "ReturnOnAssetsTTM": "-0.496", "ReturnOnEquityTTM": "-1.035", "RevenueTTM": "190000", "GrossProfitTTM": "-61366000", "DilutedEPSTTM": "-0.83", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "4.357", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "1", "AnalystRatingHold": "7", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "461.0", "PriceToBookRatio": "1.099", "EVToRevenue": "54.5", "EVToEBITDA": "-0.81", "Beta": "0.576", "52WeekHigh": "7.29", "52WeekLow": "0.64", "50DayMovingAverage": "0.778", "200DayMovingAverage": "2.744", "SharesOutstanding": "97987000", "SharesFloat": "95532000", "PercentInsiders": "1.435", "PercentInstitutions": "57.520", "DividendDate": "None", "ExDividendDate": "None"}